← back to search

Andreas Leha

University of Michigan–Ann Arbor · US
Area of research
Infectious Diseases · Molecular Biology
Research interest
Research interests include Medicine, Biology, Induced pluripotent stem cell, Computational biology, Oncology, and Phenotype.
h-index
citations
1,665
works
20
NIH funding
primary concept
email

Recent publications

Real world federated learning with a knowledge distilled transformer for cardiac CT imaging
npj Digital Medicine 2025cited by 17position: middledoi
Multi-modal dataset creation for federated learning with DICOM-structured reports
International Journal of Computer Assisted Radiology and Surgery 2025cited by 6position: middledoi
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial
The Lancet Neurology 2024cited by 28position: middledoi
Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS‐CoV‐2 vaccination
Allergy 2022cited by 24position: middledoi
Long‐term effects of homologous and heterologous <scp>SARS‐CoV</scp>‐2 vaccination on humoral and cellular immune responses
Allergy 2022cited by 6position: middledoi
Influence of Shear Stress, Inflammation and BRD4 Inhibition on Human Endothelial Cells: A Holistic Proteomic Approach
Cells 2022cited by 5position: middledoi
Single-cell RNA-sequencing of differentiating iPS cells reveals dynamic genetic effects on gene expression
Nature Communications 2020cited by 363position: middledoi
Population-scale proteome variation in human induced pluripotent stem cells
eLife 2020cited by 68position: middledoi
Fibroblast growth factor receptor 4 as a prognostic indicator in triple-negative breast cancer
Translational Cancer Research 2020cited by 15position: middledoi
Publisher Correction: Single-cell RNA-sequencing of differentiating iPS cells reveals dynamic genetic effects on gene expression
Nature Communications 2020cited by 14position: middledoi
Fibroblast Growth Factor Receptor 4 as A Prognostic Indicator in Triple-Negative Breast Cancer
Research Square 2020cited by 1position: middledoi
Epidermal Growth Factor Signaling Promotes Sleep through a Combined Series and Parallel Neural Circuit
Current Biology 2019cited by 118position: middledoi
A machine learning approach for the prediction of pulmonary hypertension
PLoS ONE 2019cited by 93position: firstdoi
Proteomic analysis of tear fluid reveals disease-specific patterns in patients with Parkinson's disease – A pilot study
Parkinsonism & Related Disorders 2019cited by 82position: middledoi
ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis
Frontiers in Neurology 2019cited by 75position: middledoi
Identifying Extrinsic versus Intrinsic Drivers of Variation in Cell Behavior in Human iPSC Lines from Healthy Donors
Cell Reports 2019cited by 41position: middledoi
Common genetic variation drives molecular heterogeneity in human iPSCs
Nature 2017cited by 635position: middledoi
A high-content platform to characterise human induced pluripotent stem cell lines
Methods 2015cited by 45position: firstdoi
Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancer
Oncotarget 2014cited by 27position: middledoi
Abstract 75: CpG methylation signature to predict outcome in preoperatively treated rectal cancer.
Cancer Research 2013cited by 2position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tim Seidler · Sequoia (United States)3 papers (2019–2025) · 3 papers (2022–2022)Tim Friede · Deutsches Herzzentrum der Charité3 papers (2019–2025)Andreas Fischer · Universitätsmedizin Göttingen3 papers (2022–2022)Xiaoshuan Liang · Harbin Medical University2 papers (2020–2020)Gerhard‐Paul Diller · University Hospital Münster2 papers (2025–2025)Peter Bannas · Indiana University2 papers (2025–2025)Marian Grade · Center for Cancer Research2 papers (2013–2014) · 2 papers (2025–2025) · 2 papers (2025–2025) · 2 papers (2022–2022) · 2 papers (2022–2022)Nathalie Moens · University of Antwerp2 papers (2015–2019) · 2 papers (2022–2022)Lars Kaderali · Institute of Bioinformatics and Systems Biology2 papers (2025–2025)Nina Krüger · Humboldt-Universität zu Berlin2 papers (2025–2025) · 2 papers (2022–2022)Paul Lingor · Technical University of Munich2 papers (2019–2019)Halvar Kelm · University Hospital Heidelberg2 papers (2025–2025)Rainer Claus · Molecular Oncology (United States)2 papers (2013–2014)